I help life science companies build and execute commercial strategies leading to successful launches and product/service line expansions. I have developed strategic roadmaps for a wide range of biotech products and services for indications spanning oncology, rare disease, neurodegenerative disease, and more. My background includes a strong track record in leading upstream and downstream marketing, market opportunity analysis, and building product portfolios. Knowledge and expertise: • Drug development spanning preclinical to clinical for cell and gene therapy, small molecules and biologics for oncology and rare disease applications • Development of products involving computational biology, bioinformatics, machine learning and AI combined with wet lab capabilities • Medical device development and commercialization for cancer applications and beyond • Precision medicine diagnostic product development experience for liquid biopsy and tissue applications • Companion diagnostics services targeting pharma customers and spanning biomarker discovery to IVD development and commercialization